Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of dioscin in preparing drug-resistant osteosarcoma medicine

The technology of protodioscin and antitumor drug is applied in the application field of protodioscin in the preparation of drug-resistant bone tumor drugs, which can solve the problems of poor treatment effect of drug-resistant osteosarcoma, and achieve the effect of broad application prospect.

Active Publication Date: 2018-07-20
THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] Aiming at the defect that existing drugs (including diosgenin) have poor therapeutic effects on drug-resistant osteosarcoma, the object of the present invention is to provide the application of protodiosgenin in the preparation of drug-resistant bone tumor drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of dioscin in preparing drug-resistant osteosarcoma medicine
  • Application of dioscin in preparing drug-resistant osteosarcoma medicine
  • Application of dioscin in preparing drug-resistant osteosarcoma medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0035] Application of Protodioscin in Inhibiting Osteosarcoma Cell Proliferation and Inducing Osteosarcoma Cell Apoptosis

[0036] The human osteosarcoma U2OS, HOS, MNNGHOS, 143B, MG63, SJSA1, G292 cell lines used in the present invention were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences; The primary human osteosarcoma cell line constructed by the Department of Bone Oncology, the First Affiliated Hospital of the University; protodioscin was purchased from Guangzhou Anbang Biotechnology Co., Ltd., and Hoechst 33258 was purchased from American Thermo Company; DMEM high-glucose medium and fetal bovine serum were purchased from Invitrogen Company; MTT kit was purchased from Sigma Company. Nude mice were purchased from Nanjing University-Nanjing Institute of Biomedicine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of dioscin in preparing a drug-resistant osteosarcoma medicine. Drug-resistant osteosarcoma refers to an osteosarcoma cell line which has drug resistance to commonanti-tumor medicines, particularly U2OS tumor cells with drug resistance to methotrexate, doxorubicin and cis-platinum. Moreover, as a natural plant extract medicine, dioscin has wide application prospects in the field of anti-tumor medicine treatment.

Description

technical field [0001] The invention belongs to the field of medicaments, and in particular relates to the application of protodioscin in the preparation of drug-resistant bone tumor medicaments. Background technique [0002] Primary osteosarcoma is a common malignant bone tumor with onset mainly in adolescence. Because of its insidious onset and rapid progress, it is mostly in the middle and late stages when it is discovered. Therefore, the effect of surgery is poor, and radiotherapy and chemotherapy have obvious adverse reactions, resulting in poor quality of life and short survival period of osteosarcoma patients. There is an urgent need for effective and safe anticancer drugs for the treatment of osteosarcoma. [0003] Under normal physiological conditions, cell proliferation is strictly regulated, and cells can metabolize through programmed death, that is, apoptosis. However, when related molecular events such as activation of oncogenes, inactivation of tumor suppres...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A61P35/00A61P19/00
CPCA61K31/7048
Inventor 沈靖南尹军强贾强刘伟海黄纲邹昌业谢显彪林熙武征赵巨鹏
Owner THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com